Skip to content
10-Q

Quarterly Report

RESMED INC RMD RSMDF

0000943819-26-000007

← back to feed
Filed
Jan 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Jan 26, 2026 145.68M sh
Shares Diluted Q2 2026 · Dec 31, 2025 146.37M sh
Shares Diluted Q2 2026 · Dec 31, 2025 146.63M sh
Shares Diluted Q2 2026 · Dec 31, 2024 147.48M sh
Shares Diluted Q2 2026 · Dec 31, 2024 147.52M sh
Stock Repurchased Q2 2026 · Dec 31, 2025 $325.02M
Stock Repurchased Q2 2026 · Dec 31, 2024 $124.99M
Dividends Paid Q2 2026 · Dec 31, 2025 $175.33M
Dividends Paid Q2 2026 · Dec 31, 2024 $155.59M
Capex Q2 2026 · Dec 31, 2025 $71.5M
Capex Q2 2026 · Dec 31, 2024 $38.48M
Operating Cash Flow Q2 2026 · Dec 31, 2025 $797.07M
Operating Cash Flow Q2 2026 · Dec 31, 2024 $634.16M
Short Term Debt Q2 2026 · Dec 31, 2025 $259.91M
Short Term Debt Q2 2026 · Jun 30, 2025 $9.9M
Cash And Equivalents Q2 2026 · Dec 31, 2025 $1.42B
Cash And Equivalents Q2 2026 · Jun 30, 2025 $1.21B
Stockholders Equity Q2 2026 · Dec 31, 2025 $6.32B
Stockholders Equity Q2 2026 · Sep 30, 2025 $6.12B
Stockholders Equity Q2 2026 · Jun 30, 2025 $5.97B
Stockholders Equity Q2 2026 · Dec 31, 2024 $5.25B
Stockholders Equity Q2 2026 · Sep 30, 2024 $5.2B
Stockholders Equity Q2 2026 · Jun 30, 2024 $4.86B
Current Liabilities Q2 2026 · Dec 31, 2025 $1.25B
Current Liabilities Q2 2026 · Jun 30, 2025 $1.02B
Total Liabilities Q2 2026 · Dec 31, 2025 $2.18B
Total Liabilities Q2 2026 · Jun 30, 2025 $2.21B
Current Assets Q2 2026 · Dec 31, 2025 $3.82B
Current Assets Q2 2026 · Jun 30, 2025 $3.51B
Total Assets Q2 2026 · Dec 31, 2025 $8.5B
Total Assets Q2 2026 · Jun 30, 2025 $8.17B
Eps Diluted Q2 2026 · Dec 31, 2025 $2.68
Eps Diluted Q2 2026 · Dec 31, 2025 $5.05
Eps Diluted Q2 2026 · Dec 31, 2024 $2.34
Eps Diluted Q2 2026 · Dec 31, 2024 $4.45
Eps Basic Q2 2026 · Dec 31, 2025 $2.69
Eps Basic Q2 2026 · Dec 31, 2025 $5.08
Eps Basic Q2 2026 · Dec 31, 2024 $2.35
Eps Basic Q2 2026 · Dec 31, 2024 $4.47
Sga Expense Q2 2026 · Dec 31, 2025 $278.4M
Sga Expense Q2 2026 · Dec 31, 2025 $537.59M
Sga Expense Q2 2026 · Dec 31, 2024 $241.61M
Sga Expense Q2 2026 · Dec 31, 2024 $480.59M
Rd Expense Q2 2026 · Dec 31, 2025 $90.97M
Rd Expense Q2 2026 · Dec 31, 2025 $178.29M
Rd Expense Q2 2026 · Dec 31, 2024 $81.37M
Rd Expense Q2 2026 · Dec 31, 2024 $160.9M
Net Income Q2 2026 · Dec 31, 2025 $392.59M
Net Income Q2 2026 · Dec 31, 2025 $741.13M
Net Income Q2 2026 · Sep 30, 2025 $348.54M
Net Income Q2 2026 · Dec 31, 2024 $344.62M
Net Income Q2 2026 · Dec 31, 2024 $655.98M
Net Income Q2 2026 · Sep 30, 2024 $311.36M
Operating Income Q2 2026 · Dec 31, 2025 $491.66M
Operating Income Q2 2026 · Dec 31, 2025 $938.2M
Operating Income Q2 2026 · Dec 31, 2024 $417.24M
Operating Income Q2 2026 · Dec 31, 2024 $804.55M
Gross Profit Q2 2026 · Dec 31, 2025 $878.72M
Gross Profit Q2 2026 · Dec 31, 2025 $1.7B
Gross Profit Q2 2026 · Dec 31, 2024 $751.28M
Gross Profit Q2 2026 · Dec 31, 2024 $1.47B
Cost Of Revenue Q2 2026 · Dec 31, 2025 $544.08M
Cost Of Revenue Q2 2026 · Dec 31, 2025 $1.06B
Cost Of Revenue Q2 2026 · Dec 31, 2024 $530.81M
Cost Of Revenue Q2 2026 · Dec 31, 2024 $1.04B
Revenue Q2 2026 · Dec 31, 2025 $1.42B
Revenue Q2 2026 · Dec 31, 2025 $2.76B
Revenue Q2 2026 · Dec 31, 2024 $1.28B
Revenue Q2 2026 · Dec 31, 2024 $2.51B